Outcome of the Board Meeting held on 15.10.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jeevan Scientific Technology's board, meeting on 15 October 2025, approved increasing authorised share capital from Rs. 21 crore to Rs. 25 crore. It cleared issuing up to 35 lakh convertible warrants at Rs. 40 each to promoters and select non-promoters, plus up to 41.85 lakh equity shares at Rs. 40 each to non-promoters, together potentially raising around Rs. 30.7 crore on a preferential basis. All four promoter-group allottees and one entity (Decibels Properties) account for the warrant portion, while 24 non-promoter investors take the equity shares; warrants must convert within 18 months or the upfront money is forfeited. Post full conversion, promoter holding is set at 38.37% and public at 61.63%, marginally diluting existing shareholders. An EGM is scheduled for 12 November 2025 to seek shareholder approval, alongside adoption of a new Memorandum of Association and reconstitution of board committees.
The Rs. 40 issue price implies a healthy premium to the Rs. 10 face value, signalling promoter confidence, but it also means meaningful dilution (roughly 30%+ in expanded capital) for existing non-participating shareholders. Stock may see short-term pressure due to equity dilution, though the promoter participation could support sentiment. Approvals from the 12 November EGM are the next trigger to watch.